| Titolo |
Pubblicato in |
Anno |
| IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
2025 |
| Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes |
DIABETES RESEARCH AND CLINICAL PRACTICE |
2025 |
| Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes |
CARDIOVASCULAR DIABETOLOGY |
2025 |
| Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk |
THE LANCET REGIONAL HEALTH. EUROPE |
2024 |
| No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study |
CLINICAL THERAPEUTICS |
2024 |
| Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2024 |
| Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2023 |
| Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials |
DIABETES, OBESITY AND METABOLISM |
2023 |
| Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
| Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2023 |
| Development of a clinical risk score to predict death in patients with COVID-19 |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2022 |
| Third dose of Covid-19 vaccine in diabetes: relevance of good metabolic control to improve its efficacy |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2022 |
| Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
2022 |
| Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia |
JOURNAL OF CLINICAL LIPIDOLOGY |
2022 |
| The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study |
ANTIOXIDANTS |
2022 |
| Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2022 |
| Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA |
FRONTIERS IN ENDOCRINOLOGY |
2022 |
| Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study |
DIABETES RESEARCH AND CLINICAL PRACTICE |
2021 |
| Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study |
DIABETIC MEDICINE |
2021 |
| Small nerve fiber damage and Langerhans cells in type 1 and type 2 diabetes and LADA measured by corneal confocal microscopy |
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE |
2021 |
